Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).


Journal

Chinese clinical oncology
ISSN: 2304-3873
Titre abrégé: Chin Clin Oncol
Pays: China
ID NLM: 101608375

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 21 03 2019
accepted: 18 04 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 10 9 2019
Statut: ppublish

Résumé

Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to invasive carcinoma. Consensus guidelines indicate surgery for IPMN at high risk of malignant progression, as assessed by specific radiological and clinical criteria, whereas an active radiological surveillance is recommended for IPMN at low risk of malignancy. The management of IPMN is further complicated by the risk of developing a distinct new cyst or a ductal adenocarcinoma in the remnant pancreas, either synchronously or metachronously. Several studies therefore investigated local progression in the remnant pancreas following partial pancreatic resection for IPMN and whether an unstable epithelium at risk for malignant degeneration may exist. Understanding the biological mechanisms behind progression of IPMN will help in identifying patients that would benefit from the resection of the entire pancreas.

Identifiants

pubmed: 31070041
doi: 10.21037/cco.2019.04.03
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

21

Auteurs

Elisabetta Sereni (E)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.

Claudio Luchini (C)

Department of Pathology, University of Verona Hospital Trust, Verona, Italy.

Roberto Salvia (R)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy.

Antonio Pea (A)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Verona, Italy. antonio.pea@univr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH